ACP-01 in Patients With Critical Limb Ischemia

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2021

Conditions
Critical Limb Ischemia
Interventions
BIOLOGICAL

ACP-01

Injection into lower extremity

BIOLOGICAL

Placebo

Injection into lower extremity

Trial Locations (19)

19140

Temple University Hosptial, Philadelphia

27157

Wake Forest Baptist Health, Winston-Salem

27401

Moses H. Cone Memorial Hospital, Greensboro

29425

Medical University of South Carolina, Charleston

32610

University of Florida, Gainesville

33126

Clinovation Research, LLC, Miami

33880

Clinical Research of Central Florida, Winter Haven

60153

Loyola University Medical Center, Maywood

62526

Decatur Memorial Hospital, Decatur

73104

University of Oklahoma Health Sciences Center, Oklahoma City

77030

Houston Methodist DeBakey Heart & Vascular Center, Houston

78229

Clinical Trials of Texas, Inc. (CTT), San Antonio

80045

Rocky Mountain Regional VA Medical Center, Aurora

95817

UC Davis CTSC Clinical Research Center, Sacramento

01655

University of Massachusetts Medical School, Worcester

Unknown

Dartmouth-Hitchcock Medical Center, Lebanon

V5Z 1K3

Vancouver General Hospital, Vancouver

N6A 5W9

London Health Sciences Centre, London

M5G 2C4

Toronto General Hospital, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hemostemix

INDUSTRY